Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy

Affiliations

L Wartofsky. J Clin Endocrinol Metab. 1995 Feb.

. 1995 Feb;80(2):347-9.

doi: 10.1210/jcem.80.2.7852488.

No abstract available

Similar articles

Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
DeGroot LJ, Gorman CA, Pinchera A, Bartalena L, Marcocci C, Wiersinga WM, Prummel MF, Wartofsky L, Marocci C [corrected to Marcocci C]. DeGroot LJ, et al. J Clin Endocrinol Metab. 1995 Feb;80(2):339-40. doi: 10.1210/jcem.80.2.7677823. J Clin Endocrinol Metab. 1995. PMID: 7677823 No abstract available.
Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
Pinchera A, Bartalena L, Marcocci C. Pinchera A, et al. J Clin Endocrinol Metab. 1995 Feb;80(2):342-5. doi: 10.1210/jcem.80.2.7852486. J Clin Endocrinol Metab. 1995. PMID: 7852486 No abstract available.
Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
Gorman CA. Gorman CA. J Clin Endocrinol Metab. 1995 Feb;80(2):340-2. doi: 10.1210/jcem.80.2.7852485. J Clin Endocrinol Metab. 1995. PMID: 7852485 No abstract available.
Graves' ophthalmopathy and 131I therapy.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Marcocci C, et al. Q J Nucl Med. 1999 Dec;43(4):307-12. Q J Nucl Med. 1999. PMID: 10731781 Review.
[Radioactive iodine (I-131) therapy].
Kusakabe K, Maki M. Kusakabe K, et al. Nihon Rinsho. 1999 Aug;57(8):1855-8. Nihon Rinsho. 1999. PMID: 10483265 Review. Japanese.